Bayer poaches GlaxoSmithKline exec to lead expanding oncology business—including a blockbuster hopeful
Oncology is hardly what Bayer is known for. But the German drugmaker has raided GlaxoSmithKline—which is itself reestablishing a cancer foothold—for a new leader in t...